FILE PHOTO: A lawyer speaks on his mobile phone as he walks past India’s Supreme Court in New Delhi April 1, 2013. India’s highest court, the Supreme Court, has dismissed Swiss drugmaker Novartis AG’s petition seeking patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms which are increasingly focusing on India to drive sales. REUTERS/Adnan Abidi (INDIA – Tags: BUSINESS HEALTH CRIME LAW)/File Photo